4 results match your criteria: "The Netherlands. s.e.ledevedec@lacdr.leidenuniv.nl.[Affiliation]"
Chem Commun (Camb)
June 2024
Leiden Academic Center for Drug Research, Leiden University, P.O. Box 9502, 2300 RA Leiden, The Netherlands.
The famous ''light-switch'' ruthenium complex [Ru(bpy)(dppz)](PF) (1) has been long known for its DNA binding properties . However, the biological utility of this compound has been hampered by its poor cellular uptake in living cells. Here we report a bioimaging application of 1 as cell viability probe in both 2D cells monolayer and 3D multi-cellular tumor spheroids of various human cancer cell lines (U87, HepG2, A549).
View Article and Find Full Text PDFSci Data
July 2023
Life Science Semantics, Leiden Institute of Advanced Computer Science, Leiden, The Netherlands.
The Minimum Information for High Content Screening Microscopy Experiments (MIHCSME) is a metadata model and reusable tabular template for sharing and integrating high content imaging data. It has been developed by combining the ISA (Investigations, Studies, Assays) metadata standard with a semantically enriched instantiation of REMBI (Recommended Metadata for Biological Images). The tabular template provides an easy-to-use practical implementation of REMBI, specifically for High Content Screening (HCS) data.
View Article and Find Full Text PDFBreast Cancer Res Treat
April 2023
Division of Drug Discovery and Safety, Leiden Academic Centre of Drug Research, Leiden University, Leiden, The Netherlands.
Hypoxia is linked to disease progression and poor prognosis in several cancers, including breast cancer. Cancer cells can encounter acute, chronic, and/or intermittent periods of oxygen deprivation and it is poorly understood how the different breast cancer subtypes respond to such hypoxia regimes. Here, we assessed the response of representative cell lines for the luminal and basal A subtype to acute (24 h) and chronic hypoxia (5 days).
View Article and Find Full Text PDFMol Biol Rep
November 2022
Division of Drug Discovery and Safety, Leiden Academic Centre of Drug Research, Leiden University, Leiden, The Netherlands.